0.5953 USD
-0.05 (-8.42%)
Overall REVB gets a fundamental rating of 2 out of 10. We evaluated REVB against 525 industry peers in the Biotechnology industry. REVB has a great financial health rating, but its profitability evaluates not so good. REVB has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
- REVB had negative earnings in the past year.
- REVB had a negative operating cash flow in the past year.
- In the past 5 years REVB always reported negative net income.
- In the past 5 years REVB always reported negative operating cash flow.
1.2 Ratios
- REVB's Return On Assets of -109.52% is on the low side compared to the rest of the industry. REVB is outperformed by 76.95% of its industry peers.
- REVB has a worse Return On Equity (-127.98%) than 61.52% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -109.52% | ||
| ROE | -127.98% | ||
| ROIC | N/A |
ROA(3y)-141.62%
ROA(5y)-213.33%
ROE(3y)-450.21%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- REVB does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- Compared to 1 year ago, REVB has more shares outstanding
- Compared to 5 years ago, REVB has less shares outstanding
- There is no outstanding debt for REVB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- REVB has an Altman-Z score of -4.96. This is a bad value and indicates that REVB is not financially healthy and even has some risk of bankruptcy.
- REVB has a Altman-Z score of -4.96. This is in the lower half of the industry: REVB underperforms 61.52% of its industry peers.
- REVB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -4.96 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- REVB has a Current Ratio of 6.92. This indicates that REVB is financially healthy and has no problem in meeting its short term obligations.
- REVB has a better Current ratio (6.92) than 69.90% of its industry peers.
- A Quick Ratio of 6.92 indicates that REVB has no problem at all paying its short term obligations.
- The Quick ratio of REVB (6.92) is better than 70.10% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.92 | ||
| Quick Ratio | 6.92 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 96.26% over the past year.
EPS 1Y (TTM)96.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%95.61%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- The Earnings Per Share is expected to grow by 14.90% on average over the next years. This is quite good.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y97.78%
EPS Next 2Y41.11%
EPS Next 3Y25.84%
EPS Next 5Y14.9%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for REVB. In the last year negative earnings were reported.
- Also next year REVB is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as REVB's earnings are expected to grow with 25.84% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.11%
EPS Next 3Y25.84%
5. Dividend
5.1 Amount
- REVB does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
REVELATION BIOSCIENCES INC / REVB FAQ
Can you provide the ChartMill fundamental rating for REVELATION BIOSCIENCES INC?
ChartMill assigns a fundamental rating of 2 / 10 to REVB.
What is the valuation status for REVB stock?
ChartMill assigns a valuation rating of 1 / 10 to REVELATION BIOSCIENCES INC (REVB). This can be considered as Overvalued.
What is the profitability of REVB stock?
REVELATION BIOSCIENCES INC (REVB) has a profitability rating of 0 / 10.
What is the financial health of REVELATION BIOSCIENCES INC (REVB) stock?
The financial health rating of REVELATION BIOSCIENCES INC (REVB) is 7 / 10.